Last Update Time:
21-Mar-2025 16:00:00
ISIN:
INE426A01027
Sector:
Realty
Symbol:
ALEMBICLTD
Alembic Limited
₹100.20
₹3.03
(3.12%)
▲
Prev. Close
₹97.17
Open
₹97.02
Close
₹100.08
Range
₹95.19 - ₹105.21
High
₹100.65
Low
₹97.02
Ind. Close
₹0.00
VWAP
₹99.71
The current stock price of Alembic Limited is ₹100.20, with a target price range between ₹95.19 and ₹105.21. The stock has experienced a price change of ₹3.03 (3.12%), reflecting recent market volatility.
Today's opening price was ₹97.02, while the previous close stood at ₹97.17.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Alembic Limited Price Chart
Alembic Limited Pre Open Market Overview: 21-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 97.02
- Previous Close Price: 97.17
- Change: -0.15%
- Total Traded Volume: 1,087
- Total Buy Quantity: 35,979
- Total Sell Quantity: 18,261
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 96.50 | 1.00 | 0.00 |
| 96.70 | 109.00 | 0.00 |
| 96.71 | 500.00 | 0.00 |
| 97.00 | 1,201.00 | 0.00 |
| 97.02 | 202.00 | 0.00 |
| 97.90 | 0.00 | 25.00 |
| 97.95 | 0.00 | 125.00 |
| 97.99 | 0.00 | 1,050.00 |
| 98.00 | 0.00 | 1,000.00 |
| 98.04 | 0.00 | 125.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 35979
Total Sell Quantity: 18261
Shareholding Patterns of Alembic Limited
Key Trade Statistics of Alembic Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 6.98 |
| Traded Value (₹ Cr.) | 6.96 |
| Total Market Cap (₹ Cr.) | 2,572.95 |
| Free Float Market Cap (₹ Cr.) | 678.35 |
| Impact cost | 0.09 |
| Quantity Traded | 697,811.00 |
| Deliverable Quantity | 307,633.00 |
| % of Quantity to Traded | 44.09 |
| Security VaR | 17.94 |
| Index VaR | N/A |
| VaR Margin | 17.94 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 21.44 |
| Face Value | 2 |
Key Price Statistics of Alembic Limited
The 52-week high for Alembic Limited was ₹169.00, recorded on 23-Aug-2024. On the other hand, the 52-week low stands at ₹78.85, with the lowest value recorded on 20-Mar-2024.
The upper band for trading is ₹116.60, and the lower band is ₹77.73. The price band is 20%.
The stock's daily volatility stands at 2.75, while the annualized volatility is 52.54. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (23-Aug-2024) | 169.00 |
| 52 Week Low (20-Mar-2024) | 78.85 |
| Upper Band | 116.60 |
| Lower Band | 77.73 |
| Price Band (%) | 20 |
| Daily Volatility | 2.75 |
| Annualised Volatility | 52.54 |
| Tick Size | 0.01 |
Key Securities Statistics of Alembic Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 22-Sep-1999 |
| Adjusted P/E | 17.56 |
| Symbol P/E | 17.56 |
| Index | NA |
| Macro-Economic Sector | Consumer Discretionary |
| Sector | Realty |
| Industry | Realty |
| Basic Industry | Residential Commercial Projects |
Security Status of Alembic Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Alembic Limited
| Subject | Date |
|---|---|
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 25-Feb-2025 |
| Retirement | 25-Feb-2025 |
| Copy of Newspaper Publication | 20-Feb-2025 |
| Notice Of Shareholders Meetings-XBRL | 19-Feb-2025 |
| Shareholders meeting | 19-Feb-2025 |
| Copy of Newspaper Publication | 08-Feb-2025 |
| Integrated Filing- Financial | 07-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 07-Feb-2025 |
Corporate Actions of Alembic Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Dividend - Rs 2.4 Per Share | 05-Aug-2024 |
| 2 | Dividend - Rs 2.20 Per Share | 03-Aug-2023 |
| 2 | Dividend - Rs 1.80 Per Share | 12-Sep-2022 |
| 2 | Annual General Meeting/Dividend - Rs 0.20 Per Share | 29-Jul-2021 |
| 2 | Annual General Meeting/Dividend - Rs 0.60 Per Share | 29-Jul-2020 |
| 2 | Annual General Meeting/Dividend - Rs 0.20 Per Share | 18-Sep-2019 |
| 2 | Demerger | 26-Aug-2019 |
| 2 | Annual General Meeting/Dividend- Re 0.20 Per Share | 27-Jul-2018 |
| 2 | Buyback | 22-Mar-2018 |
| 2 | Annual General Meeting/Dividend - Re 0.20 Per Share | 19-Jul-2017 |
| 2 | Annual General Meeting/ Dividend - Re 0.15/- Per Share | 01-Aug-2016 |
| 2 | Annual General Meeting/ Dividend - Re 0.15/- Per Share | 03-Aug-2015 |
| 2 | Annual General Meeting/Dividend Re 0.15/- Per Share | 04-Aug-2014 |
| 2 | Bonus 1:1 | 27-Sep-2013 |
| 2 | Annual General Meeting And Dividend Re.0.20 Per Share (Bc Dates Revised) | 26-Aug-2013 |
| 2 | Annual General Meeting | 02-Aug-2012 |
| 2 | Annual General Meeting (Bc Dates Revised) | 16-Aug-2011 |
| 2 | Scheme Of Arrangement | 11-Apr-2011 |
| 2 | Dividend Rs 0.50 Per Share | 21-Jul-2010 |
| 2 | Dividend-Rs.0.40 Pr Share | 17-Jul-2009 |
Board Meetings of Alembic Limited
Financial Results of Alembic Limited
Company Directory of Alembic Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.alembiclimited.com | Registered Office | Alembic Road Gorwa |
VADODARA |
| www.alembiclimited.com | Transfer Agent | MUFG Intime India Private Ltd Geetakunj 1, Bhakti Nagar Society, behind ABS Tower, Old Padra Road, |
VADODARA |
Insider Trading of Alembic Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Shreno Engineering Limited | 8110 | Buy |
| 7(2) | Mr. Chirayu Ramanbhai Amin as Managing Trustee on behalf of CRA Family Trust | 11563 | Buy |
| 7(2) | Nirayu Limited | 48681033 | Buy |
| 7(2) | Nirayu Limited | 76686070 | Buy |
| 7(2) | CRA Family Trust represented by Mr. Chirayu Ramanbhai Amin as Managing Trustee | 0 | Buy |
| 7(2) | Pranav Chirayu Amin | 0 | Sell |
| 7(2) | Nirayu Limited | 26533205 | Buy |
| 7(2) | Nirayu Limited | 11390822 | Buy |
| 7(2) | Nirayu Limited | 134046819 | Buy |
| 7(2) | Nirayu Limited | 28126323 | Buy |
| 7(2) | Nirayu Limited | 212404248 | Buy |
| 7(2) | Nirayu Limited | 1101594 | Buy |
| 7(2) | Nirayu Limited | 56695498 | Buy |
| 7(2) | Nirayu Limited | 11845138 | Buy |
| 7(2) | Nirayu Limited | 18195189 | Buy |
| 7(2) | Nirayu Limited | 23526459 | Buy |
| 7(2) | Nirayu Limited | 4432652 | Buy |
| 7(2) | Nirayu Limited | 1051117 | Buy |
| 7(2) | Pranav Amin | 0 | Buy |
| 7(2) | Malika Amin | 0 | Sell |
Annual Reports of Alembic Limited
Investor Complaints of Alembic Limited
Event Calendar of Alembic Limited
| Purpose | Details |
|---|---|
| Board meeting Rescheduled | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on January 21, 2011 to consider and approve, inter-alia, the Un-Audited Financial Results for the third quarter ended on December 31, 2010 (October 01, 2010 to December 31, 2010). The Company has now informed the Exchange that the date of the Board Meeting is postponed. The meeting of the Board of Directors of the Company will be held on January 25, 2011 (instead of January 21, 2011) to consider and approve, inter-alia, the Un-Audited Financial Results for the third quarter ended on December 31, 2010 (October 01, 2010 to December 31, 2010). |
| Demerger | The Company has informed the Exchange that a meeting of the Board of Directors of Alembic Limited and Alembic Pharmaceuticals Limited (name changed from Alembic Pharma Limited) will be held on March 31, 2011 to consider and approve reconstitution of Board due to demerger and considering other agenda items relating to demerger including fixing of record date for ascertaining the eligibility of the members to receive the equity shares of Alembic Pharmaceuticals Limited as per the Scheme of Arrangement approved by the Hon'ble High Court of Gujarat vide order dated January 24, 2011. |
| Board meeting Rescheduled | The Company had informed the Exchange regarding a Board meeting to be held on February 07, 2012 inter aila to consider and approve the Unaudited Financial Results of the Company for the Quarter ended December 31, 2011. The Company has now informed the Exchange that the Meeting of Board of Directors of the Company to consider and approve, inter alia the Unaudited Financial Results of the Company for the Quarter ended December 31, 2011, is rescheduled and now shall be held on February 14, 2012. |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended December 31, 2012 |
| Results/Dividend | Inter alia, to transact following business: 1. To consider and approve Audited Financial statements of the Company for the Financial year ended March 31, 2013 2. To consider and recommend dividend, if any, for the Financial Year ended March 31, 2013. |
| Result/Bonus | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on August 09, 2013 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2013. The Company has now informed the Exchange that at the aforesaid Board Meeting, the Board of Directors shall, inter alia also consider issue of Bonus Shares. (Purpose Revised). |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2013. |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2013. |
| Results/Others | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2013. Further, that the trading window shall remain closed from January 27, 2014 to January 31, 2014 for the above purpose. |
| Results/Dividend | Inter alia, to transact following business: 1. To consider and approve Audited Financial statements of the Company for the Financial year ended March 31, 2014 2. To consider and recommend dividend, if any, for the Financial Year ended March 31, 2014. Further, the Company has also informed that the trading window shall remain closed from May 05, 2014 to May 07, 2014 for the above purpose. |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2014. Further, the Company has also informed that the trading window shall remain closed from August 10, 2014 to August 14, 2014 for the above purpose. |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended December 31, 2014. |
| Results/Dividend | inter alia, to transact following business:1. To consider and approve Audited Financial Results of the Company for the Financial year ended March 31, 2015. 2. To consider and recommend dividend, if any, for the Financial Year ended March 31, 2015. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on June 30, 2015. |
| Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30,2015. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on December 31, 2015. |
| Results/Dividend | inter alia, to transact the following business:1. To consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2016.2. To consider and recommend dividend on Equity Shares, if any, for the financial year ended 31st March, 2016. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on June 30, 2016. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2016. Further, the Exchange is hereby informed that the trading window shall remain closed from November 8, 2016 to November 13, 2016 for the above purpose. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months period ended on December 31, 2016. |
| Results/Dividend | inter alia, to transact the following business: 1. To consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2017.2. To consider and recommend dividend on Equity Shares, if any, for the financial year ended March 31, 2017 |
| Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. |
| Results | inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2017. |
| Results | inter alia, to consider and approve the Standalone Financial Results of the Company for the quarter and nine months period ended December 31, 2017. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | Board Meeting to consider Unaudited Financial Results for the quarter and half year ended 30th September, 2018 |
| Financial Results/Other business matters | ALEMBICLTD : 03-Nov-2018 :The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held October 30, 2018 to consider Unaudited Financial Results for the quarter and half year ended September 30, 2018 .Further, the Company has now informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 03, 2018, the Board of Directors will inter alia consider and approve: a) The Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2018; and b) The Composite Scheme of Arrangement ('Scheme') comprising inter alia, of demerger of the Identified Undertaking of the Company into Shreno Limited, an unlisted public limited company. |
| Financial Results | To consider and approve the unaudited financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended Jun 30, 2019 and dividend |
| Financial Results | Inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | Board Meeting to consider Unaudited Financial Results for the quarter and nine months period ended 31st December, 2019 |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2020, dividend and other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the quarter ended Jun 30, 2024 and other business matters. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Alembic Limited
Voting Results of Alembic Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 12-AUG-2024 | AGM | To receive, consider and adopt:na. the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2024 together with the Reports of the Board of Directors and the Auditors thereon.nb. the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2024 together with the Report of the Auditors thereon. |
| 12-AUG-2024 | AGM | Ratification of Remuneration to the Cost Auditors for the financial year 2024-25. |
| 12-AUG-2024 | AGM | Payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2023-24. |
| 12-AUG-2024 | AGM | To appoint a Director in place of Mr. Udit Amin (DIN: 00244235), who retires by rotation and being eligible, offers himself for re-appointment. |
| 12-AUG-2024 | AGM | To declare dividend on equity shares for the financial year 2023-24. |
| 25-JUN-2024 | Postal Ballot | Approval of material related party transactions with Shreno Limited. |
| 25-JUN-2024 | Postal Ballot | Re-appointment of Mrs. Rati Desai (DIN: 08535681) as an Independent Director of the Company. |
| 10-AUG-2023 | AGM | To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2023 and the Reports of the Board of Directors and Auditors thereon. |
| 10-AUG-2023 | AGM | Ratification of the Remuneration to the Cost Auditors for the financial year 2023-24. |
| 10-AUG-2023 | AGM | To consider payment of commission to Mr. Udit Amin (DIN: 00244235), Non-Executive Director of the Company for the financial year 2022-23. |
| 10-AUG-2023 | AGM | To consider approval of material related party transactions with Alembic Pharmaceuticals Limited. |
| 10-AUG-2023 | AGM | To consider approval of material related party transactions with Shreno Limited. |
| 10-AUG-2023 | AGM | To re-appoint Mr. Mayank Amin (DIN:03455164) as an Independent Director of the Company. |
| 10-AUG-2023 | AGM | To appoint Dr. Girish Hirode (DIN:10145777) as an Independent Director of the Company. |
| 10-AUG-2023 | AGM | To appoint a Director in place of Mr. Abhijit Joshi (DIN: 06568584), who retires by rotation and being eligible, offers himself for re-appointment. |
| 10-AUG-2023 | AGM | To declare dividend on Equity Shares for the financial year 2022-23. |
| 20-SEP-2022 | AGM | To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2022 and the reports of the Board of Directors and Auditors thereon. |
| 20-SEP-2022 | AGM | To consider re-appointment of Statutory Auditors of the Company and to fix their remuneration. |
| 20-SEP-2022 | AGM | To appoint a Director in place of Mr. Chirayu Amin (DIN: 00242549), who retires by rotation and being eligible, offers himself for re-appointment. |
| 20-SEP-2022 | AGM | To declare dividend on Equity Shares for the financial year 2021-22. |
FAQs on Alembic Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.